2009
DOI: 10.1002/humu.21078
|View full text |Cite
|
Sign up to set email alerts
|

Genetic variations as cancer prognostic markers: review and update

Abstract: Cancer molecular epidemiology traditionally studies the relationship between genetic variations and cancer risk. However, recent studies have also focused on disease outcomes. The application and design of disease outcome studies have been an extension of disease risk assessment. Yet there are a number of unique considerations important in outcome assessments. We review how genetic approaches used for disease susceptibility, such as candidate gene and genome-wide association study (GWAS) approaches, can be ada… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
27
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 33 publications
(28 citation statements)
references
References 92 publications
1
27
0
Order By: Relevance
“…Similar results have been obtained for other complex diseases including neurological disorders (Simon-Sanchez and Singleton, 2008;Bertram and Tanzi, 2009), autoimmune diseases (Lettre and Rioux, 2008;Graham et al, 2009), cardiovascular disease (Arking and Chakravarti, 2009) and a number of different cancers (Savas and Liu, 2009) following multiple large genome-wide studies.…”
Section: Discussionsupporting
confidence: 69%
“…Similar results have been obtained for other complex diseases including neurological disorders (Simon-Sanchez and Singleton, 2008;Bertram and Tanzi, 2009), autoimmune diseases (Lettre and Rioux, 2008;Graham et al, 2009), cardiovascular disease (Arking and Chakravarti, 2009) and a number of different cancers (Savas and Liu, 2009) following multiple large genome-wide studies.…”
Section: Discussionsupporting
confidence: 69%
“…Though traditional biomarkers such as tumor size, disease stage, and oral habits are reliable indicators of oral cancer prognostication, interpatient variability should also be taken into consideration [28]. Genetic variants can influence the treatment outcome and could be applied to clinical decisionmaking [29].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it is possible that AKNA expression plays a role in mechanisms that, if altered, could result in systemic and potentially fatal disorders. In keeping with this hypothesis, human AKNA is encoded by a single gene located within the FRA9E region of chromosome 9q32 [19], a common fragile site (CFS) linked to loss-of-function mutations that often lead to inflammatory and neoplastic diseases [20][21][22]. The recent finding that single nucleotide polymorphisms (SNP) within the human AKNA AT-hook domain increase the risk of cervical cancer [23] lends support to this concept.…”
Section: Introductionmentioning
confidence: 93%